Learning Center
Development of an Evidence-Based List of Vesicant Medications and Solutions [virtual]
Extravasation may result in severe patient injuries including scarring, permanent functional impairment, and even loss of a limb. Such injuries are preventable when clinicians identify which medications and solutions are vesicants, understand infusion-related risks, and implement preventative interventions. Vesicant medications and solutions not used in cancer treatment are commonly administered by nonspecialty nurses, often via peripheral intravenous (IV) catheters. There are critical issues and risks especially related to peripheral vesicant administration, increasingly via midline catheters. An INS task force was formed to review and update the 2017 vesicant list, identify current issues and risks relative to vesicant administration, and revise the extravasation prevention checklist. In this session, the task force, in a panel presentation, will present the updated 2023 vesicant list and discuss critical issues in extravasation prevention.
Learning Objectives: At the conclusion of this session, participants will be able to:
- Identify vesicant medications and solutions.
- Examine issues associated with peripheral vesicant administration.
- Analyze extravasation prevention strategies.
- Apply extravasation prevention strategies in their health care organization.
Contact Hours: 1
CRNI® RUs: 2
Lynn Hadaway, M.Ed., RN, NPD-BC, CRNI®
Lynn Hadaway has 50 years of experience in infusion nursing. Her clinical experience comes from infusion therapy teams in multiple acute care settings. She is president of Lynn Hadaway Associates, Inc., an education and consulting company started in 1996. She holds two national certifications—infusion nursing from the Infusion Nurses Certification Corporation and nursing professional development from the American Nurses Credentialing Corporations—as well as a master’s in education from the University of Georgia. She has authored more than 75 published articles and 8 textbook chapters on infusion therapy and vascular access and was the clinical editor for Infusion Therapy Made Incredibly Easy. She served on the Infusion Nurses Society Standards of Practice committees to revise the 2006, 2011, 2016, and 2021 Standards of Practice, and served on the committees to revise the 2014 and 2022 Society for Healthcare Epidemiology of America Compendium (SHEA) CLABSI chapter and the 2015 Association for Professionals in Infection Control and Epidemiology (APIC) CLABSI Implementation Guide.
Barb Nickel, APRN-CNS, CCRN, CRNI®
Barb Nickel, APRN-CNS, CCRN, CRNI®, is a Clinical Nurse Specialist, specializing in critical care and vascular access. Her role includes staff development, quality improvement, and clinical consultation. She has presented nationally and published on infusion therapy. She was chair of the 2024 INS Standards of Practice Committee and is chair of the newly forming 2027 Standards of Practice Committee.
Lisa Gorski, MS, RN, HHCNS-BC, CRNI®, FAAN
Lisa Gorski has worked for over 35 years as a clinical nurse specialist (CNS)/educator for Wheaton Franciscan Home Health and Hospice, now Ascension at Home. Lisa is the author of more than 70 book chapters and journal articles and is the author of several books. She has served as the INS president from 2007-2008 and as the chair of the INS Standards of Practice Committee from 2009 to 2021, and is the cochair for the 2024 Standards. She is also the leader of the INS Vesicant Task Force. She speaks nationally and internationally on standards development, home health care, and infusion therapy/vascular access.
Key:
Complete
Next
Failed
Available
Locked